Impaired transporter associated with antigen processing (TAP) function attributable to a single amino acid alteration in the peptide TAP subunit TAP1

Journal of Immunology

Volumn 170, Issue 2, 2003, Pages 941-946

  Ritz, Ulrike ^a   Drexler, Ingo ^b   Sutter, Dirk ^c   Abele, Rupert ^d   Huber, Christoph ^a   Seliger, Barbara ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATE; ALANINE; AMINO ACID; COMPLEMENTARY DNA; GLUTAMIC ACID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PHENYLALANINE;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL CULTURE; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0037438346     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.2.941     Document Type: Article

References (31)

1. Monaco, J. J., S, Cho, and M. Attaya. 1990. Transport protein genes in the murine MHC: possible implications for antigen processing. Science 250:1723.
2. Pastan, I. H., and M. M. Gottesmann. 1988. Molecular biology of multidrug resistance in human cells. Important Adv. Oncol. 5:3.
3. Riordan, J. R., and X. B. Chang. 1992. CFTR, a channel with the structure of a transporter. Biochim. Biophys. Acta 1101:221.
4. Nunes, V., M. Chillon, T. Dörk, B. Tümmler, T. Casals, and X. Estivill. 1993. A new missense mutation (E92K) in the first transmembrane domain of the CFTR gene causes a benign cystic fibrosis phenotype. Hum. Mol. Genet. 2:79.
5. Schaedel, C., A. Kristoffersson, R. Kornfält, and L. Holmberg. 1994. A novel cystic fibrosis mutation. Y109C, in the first transmembrane domain of CFTR. Hum. Mol. Genet. 3:1001.
6. - channels with altered pore properties. Nature 362:160.
7. Loo, T. W., and D. M. Clarke. 1993. Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein. J. Biol. Chem. 268:19965.
8. Beaudet, L., I. L. Urbatsch, and P. Gros. 1998. Mutations in the nucleotidebinding sites of P-glycoprotein that affect substrate specificity modulate substrate induced ATP activity. Biochemistry 37:9073.
9. Neefjes, J. J., F. Momburg, and G. J. Hämmorling. 1993. Selectivity and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 261:769.
10. Russ, G., F. Esquivel, J. W. Yewdell, P. Cresswell, T. Spies, and J. R. Bennink. 1995. Assembly, intracellular location and nucleotide binding properties of the human peptide transporters TAP1 and TAP2 expressed by recombinant vaccinia virus. J. Biol. Chem. 270:21312.
11. Uebel, S., T. H. Meyer, W. Kraas, S. Kienle, G. Jung, K. H. Wiesmüller, and R. Tampé. 1995. Requirement for peptide binding to the human transporter associated with antigen processing revealed by peptide scans and complex peptide libraries. J. Biol. Chem. 270:18512.
12. Nijenhuis, M., and G. J. Hämmerling. 1996. Multiple regions of the transporter associated with antigen processing (TAP) contribute to its peptide binding site. J. Immunol. 157:5467.
13. Vos, J. C., P. Spee, F. Momburg, and J. Neefjes. 1999. Membrane topology and dimerization of the two subunits of the transporter associated with antigen processing reveal a three domain structure. J. Immunol. 163:6679.
14. Ritz, U., F. Momburg, H. P. Pircher, D. Strand, C. Huber, and B. Seliger. 2001. Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function. Int. Immunol. 13:31.
15. Knittler, M. R., P. Alberts, E. V. Deverson, and J. C. Howard. 1999. Nucleotide binding by TAP mediates association with peptide and release of assembled MHC class I molecules. Curr. Biol. 9:999.
16. Gorbulev, S., R. Abele, and R. Tampe. 2001. Allosteric crosstalk between peptide binding, transport and ATP-hydrolysis of the ABC transporter TAP. Proc Natl. Acad. Sci. USA 98:3732.
17. Lapinski, P. E., R. R. Neubig, and M. Rhagavan. 2001. Walker A lysine mutations of tap1 and tap2 interfere with peptide translocation but not peptide binding. J. Biol. Chem. 276:7526.
18. Arora, S., P. E. Lapinski, and M. Raghavan. 2001. Use of chimeric proteins to investigate the role of TAP structural domains in peptide binding and translocation. Proc. Natl. Acad. Sci. USA 98:7241.
19. Karttunen, J. T., P. J. Lehner, S. S. Gupta, E. W. Hewitt, and P. Cresswell. 2001. Distinct functions and cooperative interaction of the subunits of TAP. Proc. Natl. Acad. Sci. USA 98:7431.
20. Kallfelz, M., D. Jung, C. Hilmes, A. Knuth, E. Jaeger, C. Huber, and B. Seliger. 1999. Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer. Int. J. Cancer 81:125.
21. + T cells. Cell 71:1205.
22. De la Salle, H., J. Zimmer, D. Fricker, C. Angenieux, J. P. Cazenave, M. Okubo, H. Meada, A. Plebani, M. M. Tongio, A. Dormoy, and D. Hanau. 1999. HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J. Clin. Invest. 103:R9.
23. Wölfel, T., J. Schneider, K. H. Meyer zum Buschenfelde, H, G. Rammensee, O. Rotzschke, and K. Falk. 1994. Isolation of naturally processed peptides recognized by cytolytic T lymphocytes on human melanoma cells in association with HLA-A2.1. Int. J. Cancer 57:413.
24. Meyer, T., P. M. van Endert, S. Uebel, B. Ehring, and R. Tampé. 1994. Functional expression and purification of the ABC transporter complex associated with antigen processing (TAP) in insect cells. FEBS Lett. 351:443.
25. Neefjes, J., E. Gottfried, J. Roelse, M. Grommé, R. Obst, G. J. Hämmerling, and F. Momburg. 1995. Analysis of fine specificity of rat, mouse and human TAP peptide transporters. Eur. J. Immunol. 25:1133.
26. Bernhard, H., J. Karbach, T. Wolfel, P. Busch, S. Storkel, M. Stockle, C. Wolfel, B. Seliger, C. Huber, and K. H. Meyer zum Buschenfelde. 1994. Cellular immune response to human renal cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocytes (CTL). Int. J. Cancer 59:837.
27. Drexler, I., E. Antunes, M. Schmitz, T. Wölfel, C. Huber, V. Erfle, P. Rieber, M. Theobald, and G. Sutter. 1999. Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen AA*0201-restricted cytotoxic T-cells in vitro and in vivo. Cancer Res. 59:4955.
28. Taguchi, Y., K. Kino, M. Morishima, T. Komano, S. E. Kane, and K. Ueda. 1997. Alteration of substrate specificity by mutations at the His61 position in predicted transmembrane domain 1 of human MDR1/P-glycoprotein. Biochemistry 36:8883.
29. Loo, T. W., and D. M. Clarke. 1994. Mutations to amino acids located in predicted transmembrane segment 6 modulate the activity and substrate specificity of human P-glycoprotein. Biochemistry 33:14049.
30. Yewdell, J. W., F. Esquivel, D. Arnold, T. Spies, L. C. Eisenlohr, and J. R. Bennink. 1993. Presentation of numerous viral peptides to mouse MHC class I restricted T lymphocytes is mediated by the human MHC-encoded transporter or by a hybrid mouse-human transporter. J. Exp. Med. 177:1785.
31. Saveanu, L., S. Daniel, and P. M. van Endert. 2001. Distinct functions of the ATP binding cassettes of transporters associated with antigen processing: a mutational analysis of Walker A and B sequences. J. Biol. Chem. 276:22107.